Thermascan Inc said the U.S. Food andDrug Administration has approved clinical trials of a new,advanced AIDS confirmation test developed by the company.    Thermascan said that about 10,000 trials will be taken onthe the new test, called Fluorognost in the next three monthsthrough blood banks, hospitals and health centers as well as byindividual physicians.    The trials will be conducted in New York at the Beth IsraelMedical Centre, the Sacremento Medical foundation Blood Center,the Karolinska Institute, Stockholm, and the Institute ofHygiene at the University of Innspruck. Reuter&#3;